These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38049786)

  • 21. Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy.
    Karadeniz M; Erdogan M; Cetinkalp S; Berdeli A; Eroglu Z; Ozgen AG
    Endocrine; 2010 Jun; 37(3):513-7. PubMed ID: 20960176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between MCP-1-2518A/G polymorphism and the risk of Alzheimer's disease.
    Wang Y; Huang S; Wu X; Wang Y; Jiang D
    J Neural Transm (Vienna); 2018 Dec; 125(12):1781-1786. PubMed ID: 30284076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte chemoattractant protein-1 (MCP-1)-2518 A/G polymorphism and lupus nephritis risk: A PRISMA-compliant meta-analysis.
    Sang GY; Meng CR; Hao YF; Dai JH
    Medicine (Baltimore); 2017 Dec; 96(51):e9401. PubMed ID: 29390552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
    Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
    Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between AGTR1 A1166C polymorphism and the susceptibility to diabetic nephropathy: Evidence from a meta-analysis.
    Zhuang Y; Niu F; Liu D; Sun J; Zhang X; Zhang J; Guo S
    Medicine (Baltimore); 2018 Oct; 97(41):e07689. PubMed ID: 30313019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of
    Cao M; Tian Z; Zhang L; Liu R; Guan Q; Jiang J
    Oncotarget; 2017 Dec; 8(63):106926-106934. PubMed ID: 29291000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations of MCP-1 -2518A>G polymorphism and serum levels with cerebral infarction risk: a meta-analysis.
    Gao HH; Gao LB; Wen JM
    DNA Cell Biol; 2014 Aug; 33(8):522-30. PubMed ID: 24720638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of TNF-α-308G/A Polymorphism on the Risk of Diabetic Nephropathy and Diabetic Retinopathy: An Updated Meta-Analysis.
    Liu M; Shang M; Wang Y; Li Q; Liu X; Yang L; Zhang Q; Zhang K; Liu S; Nie F; Zeng F; Wen Y; Liu W
    Horm Metab Res; 2020 Oct; 52(10):724-731. PubMed ID: 32369834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between angiotensinogen M235T polymorphisms and the risk of diabetic nephropathy: A meta-analysis.
    Zhou B; Wen M; Mi L; Hu CJ; Zhang Y; Wang JT; Tang L
    Diabetes Res Clin Pract; 2018 Aug; 142():26-36. PubMed ID: 29775675
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Han Q; Geng W; Zhang D; Cai G; Zhu H
    J Diabetes Res; 2020; 2020():5158497. PubMed ID: 32685557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between MCP-1 2518 A>G gene polymorphism and chronic kidney disease.
    Mao S; Wu L
    Int Urol Nephrol; 2018 Dec; 50(12):2245-2253. PubMed ID: 30109559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.
    Younas H; Ijaz T; Choudhry N
    PLoS One; 2022; 17(2):e0264038. PubMed ID: 35176079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.
    Guan H; Xia MD; Wang M; Guan YJ; Lyu XC
    Medicine (Baltimore); 2020 Aug; 99(35):e21558. PubMed ID: 32871871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
    Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
    Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between the
    Lee DH; Won GW; Lee YH; Ku EJ; Oh TK; Jeon HJ
    J Korean Med Sci; 2019 Jun; 34(24):e171. PubMed ID: 31222984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.
    Wang Y; Zhou M; Wang Y; Jiang D; Deng X
    J Neural Transm (Vienna); 2019 Nov; 126(11):1465-1470. PubMed ID: 31471711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
    Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
    Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Interleukin-6 -174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes: A Meta-analysis.
    Cui ZH; Lu XT; Xiao KL; Chen Y; Li HQ
    Curr Med Sci; 2019 Apr; 39(2):250-258. PubMed ID: 31016518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.